Solta Medical launches Fraxel FTX skin resurfacing system in Australia

Solta Medical, the aesthetics unit of Bausch Health, will start offering Fraxel FTX skin-resurfacing systems to Australian healthcare practitioners on Sept. 1, 2026.

• The launch extends access to the next-generation Fraxel platform in Australia, targeting treatment precision, workflow efficiency and patient comfort.
• The system uses dual wavelengths of 1,927 nm for the epidermis and 1,550 nm for the deeper dermis.
• Fraxel FTX includes AccuTRAC optical tracking, a redesigned handpiece, integrated cooling and an updated user interface.